Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Other financing activities (2019 - 2022)

Volitionrx (VNRX) has disclosed Other financing activities for 3 consecutive years, with $30196.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Other financing activities changed N/A year-over-year to $30196.0, compared with a TTM value of $112484.0 through Dec 2022, down 76.63%, and an annual FY2022 reading of $180472.0, up 38.37% over the prior year.
  • Other financing activities was $30196.0 for Q4 2022 at Volitionrx, down from $82288.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $333969.0 in Q1 2020 and bottomed at -$234998.0 in Q2 2019.
  • Average Other financing activities over 3 years is $74409.2, with a median of $84932.5 recorded in 2019.
  • Peak annual rise in Other financing activities hit 281.34% in 2020, while the deepest fall reached 281.34% in 2020.
  • Year by year, Other financing activities stood at $147423.0 in 2019, then surged by 126.54% to $333969.0 in 2020, then tumbled by 90.96% to $30196.0 in 2022.
  • Business Quant data shows Other financing activities for VNRX at $30196.0 in Q4 2022, $82288.0 in Q3 2022, and $333969.0 in Q1 2020.